Pre-diabetic
15
2
2
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
13.3%
2 terminated out of 15 trials
81.8%
-4.8% vs benchmark
13%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 9 completed trials
Clinical Trials (15)
Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition
The GRoceries Aimed at Increasing Nutrition Study
Targeted Precision Nutrition Strategy To Prevent Chronic Metabolic Diseases
Evaluation of the Ottawa Model for Smoking Cessation in Diabetes Education Programs
Effect of 1,25-dihydroxyvitamin D3, Treatment on Insulin Secretion and Muscle Strength in Pre-diabetic Persons
Personalized Glucose Optimization Through Nutritional Intervention
Sleep Effectiveness and Insulin and Glucose Homeostasis
The Effect of Insoluble Yeast Beta-glucan Intake on Pre-diabetic Patients
Feasibility of an Interval Exercise and Nutrition Intervention to Reduce Cardiovascular Disease Risk Factors
Investigation of the Ability of a Supplement to Increase Good Bacteria in the Human Intestine and Blood Sugar Levels
The Effect of Acute Lysine Administration on α-aminoadipic Acid
Effects of a Wholegrain Diet on Body Composition and Energy Balance
The Effect of Oral Carnitine Supplementation on MRS-derived Mitochondrial Function
A Mobile Based Diabetes Prevention Program
Efficacy and Safety of DLBS3233 in Prediabetic Patients